The global thrombolysis market is anticipated to grow at a significant CAGR of 5.9% during the forecast period. Thrombolysis is also known as thrombolytic therapy. It is a treatment used to dissolve clots in blood vessels. It improves blood flow and prevents damage to tissues and organs. It is used as an emergency treatment to dissolve clots which are the main cause of heart attack and ischemic strokes. The global thrombolysis market is influenced by various factors which include the growing incidence and prevalence of blood-related diseases such as deep vein thrombosis, pulmonary embolism, strokes, and heart attack. There are favorable reimbursement policies that are driving the market. The increasing geriatric population and obesity is the main cause of clotting which lead to the growth of the market. Thrombolysis is considered the emergency medical service to dissolve the blood clots from the arteries that feed the heart and the brain. This advantage of thrombolysis helps the growth of the market. According to the Centers for Diseases Control and Prevention (CDC), in 2020, 1 in 6 deaths from cardiovascular disease was due to stroke, and every 40 seconds someone in the US has a stroke. Every 3.5 minutes, someone dies of a stroke. These factors are contributing to the growth of the global thrombolysis market.

Rising awareness through promotional initiatives and campaigns across the globe, rising healthcare expenditure, technological advancement, and excessive collaborations between market players create future opportunities for the growth of the market. Although various factors hinder the growth of the market such as side effects of the treatment, high cost of the medicines and treatment, and lack of healthcare infrastructure in low economic countries.

Impact of COVID-19 Pandemic on Global Thrombolysis  Market

During the COVID-19 pandemic, travel restrictions created hurdles to international trade and transportation, which disrupted the supply chain for the thrombolysis market, and created a temporary decline in demand due to uncertainty in the global economy. The pandemic created a global decline in the volume of stroke hospitalizations, IVT, and interfacility IVT transfers. Stroke centers and hospitals experienced a decline in the number of patients due to the number of COVID-19 patients on the rise. Thus there was a lack of medical treatment for the strokes, and heart patients temporarily.

Segmental Outlook 

The global thrombolysis market is segmented based on drug types, applications, and end-users. Based on drug types the market is segmented into fibrin-specific drugs and non- fibrin-specific drugs. Based on application, the market is sub-segmented into deep vein thrombosis, acute ischemic strokes, pulmonary embolism, acute myocardial, and blocked catheters. Based on end-users, the market is sub-segmented into hospitals and ambulatory surgical centers.

Global Thrombolysis Market Share by End User, 2021 (%) 

The Hospitals Segment is Expected to Hold a Prominent Share in the Global Thrombolysis  Market

Based on end-user, the hospital segment is projected to hold a prominent share of the global thrombolysis market. Thrombolytic therapy is the use of drugs to break up or dissolve blood clots, which are the main cause of both heart attacks and stroke. Owing to the proper guidance and the support of a professional doctor, patients tend to visit hospitals more. According to Stroke Association, thrombolysis requires to be given within four and a half hours of your stroke symptoms starting or according to the doctor, hence the hospital segment will contribute to the growth of the market.

Regional Outlooks

The global thrombolysis market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America). The market can be analyzed for a particular region or country level as per the requirement. The North American region is anticipated to be the fastest-growing region in the global thrombolysis market, owing to the rising incidence of thrombosis. According to CDC, in the US around 900,000 people are affected by deep vein thrombosis every year.

Global Thrombolysis Market Growth, by Region 2022-2028

Europe Accounts to Register a Significant Share in the Global Thrombolysis  Market 

Europe contributes a significant share of the global thrombolysis market, due to the high rate of diagnosis and treatment, the ability to introduce innovation by investing in R&D activities, and the presence of good healthcare facilities. According to the European Heart Network, each year cardiovascular disease (CVD) causes 3.9 million deaths in Europe. Death rates from both ischaemic heart disease (IHD) and stroke are generally higher in Central and Eastern Europe than in Northern, Southern, and Western Europe. Due to this the diagnosis and treatment in Europe are increasing and growing the global thrombolysis market.

Market Players Outlook

The major companies serving the global thrombolysis market include Genentech, Microbix, F. Hoffmann-La Roche Ltd., Livzon Diagnostics, Mochida Pharmaceutical Co., Ltd., and Others. The companies are focusing on product innovations, expansions, mergers, and acquisitions, partnerships, collaborations, and finding a new market or innovation in their core competency to expand individual market share. For instance, in 2021, Inari Medical partnered with Aidoc to advance the timely detection and treatment of Pulmonary Embolism. Through this acquisition, the company aims to accelerate the adoption and the clinical impact of AI to advance the timely detection and treatment of pulmonary embolism (“PE”).

The Report Covers

• Market value data analysis of 2021 and forecast to 2028.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global thrombolysis market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.